The Ensign Group, Inc. (ENSG) Earnings Call Transcripts

The Ensign Group, Inc.'s Latest Earnings Call - Q1 FY2026

The Ensign Group, Inc. reported strong results for Q1 2026, with significant growth in both revenue and earnings. Revenue reached $1.4 billion, marking an 18.4% increase year-over-year, while GAAP diluted EPS rose by 21.9% to $1.67. The company raised its annual 2026 earnings guidance to $7.48-$7.62 per diluted share, up from $7.41-$7.61, and increased revenue guidance to $5.81-$5.86 billion, reflecting confidence in continued operational strength and recent acquisitions. Management highlighted record occupancy rates and robust skilled mix growth, driven by high-quality clinical outcomes and strategic acquisitions.

Reported metrics

Guidance from management

Management raised annual 2026 earnings guidance to $7.48-$7.62 per diluted share and revenue guidance to $5.81-$5.86 billion, citing strong Q1 performance and recent acquisitions.

What management said

Yes. I mean that's a comment that just relates to -- over the next several months, right? I think obviously, who we expect them to be very, very successful and accretive like you said, like we've done for years.

So we're really excited about the guidance. The guidance raise. I mean, obviously reflects the strong Q1, but also that continued execution some seasonality in there for Q2 and Q3 because that's through the summer months. And we also usually have not as high as skilled mix during those months. and then costs rise as relative to the revenue that we bring in because the acuity tends to slow down a little bit.

What analysts pressed on

Analysts questioned the impact of clinical reviews on managed care volumes and the contribution of recent acquisitions to EPS guidance. Management reassured that clinical reviews are a normal part of operations and that acquisitions are expected to be accretive over time.

Main topics on the call

• Occupancy and Skilled Mix Growth — The company achieved record highs in same-store and transitioning occupancy at 84.3% and 85.1%, respectively. Skilled revenue and days increased by 9.6% and 5.1%, and Medicare revenue rose by 9.8% and 9.2%. Management em...
• Acquisition Strategy — Ensign added 22 new operations, including 21 real estate assets, expanding its portfolio significantly. Management noted that these acquisitions are expected to be accretive over time, stating, 'we continue to acquire ne...
• Guidance Increase — The company raised its annual 2026 earnings guidance to $7.48-$7.62 per diluted share and revenue guidance to $5.81-$5.86 billion. This reflects a 15% increase over 2025 earnings, driven by strong Q1 performance and rece...
• Labor and Staffing Improvements — Ensign reported improvements in turnover and stable wage growth, with a 32% decline in turnover among directors of nursing over the past two years. Management highlighted 'exceptionally low turnover' as a key driver of c...

Read the full The Ensign Group, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 26 The Ensign Group, Inc. earnings call transcripts on record, spanning February 6, 2020 to July 29, 2026. Based on this history, The Ensign Group, Inc. reports quarterly. The most recent call on file is dated July 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

ENSG

Exchange

NasdaqGS

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

26

First call

February 6, 2020

Most recent

July 29, 2026

Reporting cadence

quarterly